Skip to main content
. 2025 Jun 30;11(3):01085-2024. doi: 10.1183/23120541.01085-2024

FIGURE 3.

FIGURE 3

Prevalence of cardiometabolic disease among participants with different combinations of elevated biomarkers of type 2 inflammation: a) diabetes, b) cardiovascular disease (CVD) and c) hypertension. FENO: exhaled nitric oxide fraction.